NxStage Medical (NSDQ:NXTM) today touted data from studies of its Nx2me connected health technology and home hemodialysis systems, which the company plans to present at the 2016 Annual Dialysis Conference in Seattle later this month.
In a study of 328 patients treated with the company’s HHD using its Nx2me platform, NxStage reported a 44% reduction in controllable dropout when compared against patients not treated with the telehealth system.
The Nx2me Connected Health technology is a system focused through the Nx2me app that leverages tablets, cloud computing and wireless communications to collect home hemodialysis data in addition to patient information like blood pressure and weight. Patients can review, confirm, and transmit this data to their centers after each treatment.
“Home hemodialysis therapy, particularly when done more frequently, clearly has life-changing benefits. Because the training required to go home involves investment of time for both the dialysis provider and the patient, it is essential that training is efficient and that patients are able to continue to do their dialysis at home for as long as they can. We’re delighted that our depth of experience and our investment in breakthrough technologies with Nx2me allow us to give providers additional tools to optimize their and their patients’ successes,” prez Joseph Turk said in prepared remarks.
In another study, data from 11,153 patients trained in 1,108 centers showed an increase incidence of kidney transplantation and decreased patient dropout from home hemodialysis after HHD program training.
“With these findings, we hope to educate the attending medical community both on practices for increasing home hemodialysis patient retention, and the technological advancements NxStage is implementing to help more patients reap the benefits associated with home hemodialysis therapy,” Dr. Eric Weinhandl of the University of Minnesota said in a press release.
Last August, NxStage announced 3 new products in the pipeline for the dialysis-focused device company during a conference call discussing their quarterly earnings.
Included in the announcements was a next-generation portable hemodialysis system usable at home or in care centers, a new, simplified peritoneal dialysis machine and a critical care system. The next-generation hemodialysis system will take a pioneering approach to water purification and dialysate, CEO Jeff Burbank said on the call.
The post NxStage touts home hemodialysis studies appeared first on MassDevice.
from MassDevice http://ift.tt/1T7Gtvk
Cap comentari:
Publica un comentari a l'entrada